Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
Ann Clin Transl Neurol. 2020 Sep;7(9):1716-1725. doi: 10.1002/acn3.51151. Epub 2020 Aug 10.
Neuronal intranuclear inclusion disease (NIID) is a clinically heterogeneous neurodegenerative condition characterized by pathological intranuclear eosinophilic inclusions. A CGG repeat expansion in NOTCH2NLC was recently identified to be associated with NIID in patients of Japanese descent. We screened pathologically confirmed European NIID, cases of neurodegenerative disease with intranuclear inclusions and applied in silico-based screening using whole-genome sequencing data from 20 536 participants in the 100 000 Genomes Project. We identified a single European case harbouring the pathogenic repeat expansion with a distinct haplotype structure. Thus, we propose new diagnostic criteria as European NIID represents a distinct disease entity from East Asian cases.
神经元核内包涵体病(NIID)是一种临床表现多样的神经退行性疾病,其特征为核内嗜酸性包涵体的病理性存在。最近发现 NOTCH2NLC 中的 CGG 重复扩增与日本裔 NIID 患者相关。我们筛选了经病理学证实的欧洲 NIID、具有核内包涵体的神经退行性疾病病例,并对来自 100000 基因组计划的 20536 名参与者的全基因组测序数据进行了基于计算机的筛选。我们发现了一个携带致病性重复扩增的单一欧洲病例,其具有独特的单倍型结构。因此,我们提出了新的诊断标准,因为欧洲 NIID 代表了与东亚病例不同的疾病实体。